Shares of Starpharma Holdings Limited (OTCMKTS:SPHRY – Get Free Report) rose 8.1% during trading on Thursday . The company traded as high as $0.76 and last traded at $0.76. Approximately 4,300 shares traded hands during mid-day trading, an increase of 231% from the average daily volume of 1,300 shares. The stock had previously closed at $0.70.
Starpharma Stock Up 6.0 %
The company has a debt-to-equity ratio of 0.07, a quick ratio of 4.58 and a current ratio of 4.94. The company’s 50 day moving average price is $0.69 and its two-hundred day moving average price is $0.64.
Starpharma Company Profile
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom.
Recommended Stories
- Five stocks we like better than Starpharma
- How to invest in marijuana stocks in 7 steps
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- How to Read Stock Charts for Beginners
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- Trading Halts Explained
- MarketBeat Week in Review – 01/13 – 01/17
Receive News & Ratings for Starpharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Starpharma and related companies with MarketBeat.com's FREE daily email newsletter.
